Le Lézard
Classified in: Health, Business
Subject: CSR

TD Advances Innovation in Canadian Healthcare


Commits $2.5 million to support University of Toronto's Creative Destruction Lab Health Stream

Layer 6 to apply globally-recognized deep learning team to advance personalized treatment plans for people with diabetes

TORONTO, Oct. 11, 2018 /CNW/ - TD Bank Group (TD) today announced two initiatives as part of its commitment to invest in innovation and healthcare to create more equitable outcomes for Canadians.

Funding Healthcare Breakthroughs

Launched at the Rotman School in August 2012, University of Toronto's Creative Destruction Lab (CDL), aims to bring aspiring entrepreneurs and technological innovations to market. TD will become a Corporate Founding Member of the CDL Health Stream with a $2.5 million contribution over five years, operating out of the CDL-Toronto and CDL-West locations. The CDL's Health Stream focuses on biotechnology, bioinformatics, diagnostics and digital care for Canadians.

"The University of Toronto has a deep history of healthcare innovation, dating back to the discovery of insulin in 1921. Thanks to TD, the Creative Destruction Lab's Health Stream can accelerate its programming and continue to build on this legacy to bring a whole new generation of medical breakthroughs to life," says Sonia Sennik, Executive Director of the Creative Destruction Lab.

The CDL's emphasis on more equitable healthcare outcomes for Canadians aligns with TD's recent launch of The Ready Commitment, where the bank has targeted $1 billion for community giving in critical areas of need including better health and healthcare.

"We know that the long-term success of our business depends upon the resilience and health of the people we serve. We're thrilled to support the CDL with this contribution, which will help accelerate advances in healthcare through fresh thinking and entrepreneurship," says Andrea Barrack, TD's Vice President of Global Corporate Citizenship. "At TD, we have a history and meaningful purpose of helping to enrich the lives of customers, colleagues and communities."

Powering the Future of Personalized Healthcare

Layer 6, TD's global Artificial Intelligence (AI) thought leader and pioneer in the delivery of responsive, personalized and insight-driven experiences, was one of the first companies in the world to apply deep learning to solve today's banking and enterprise business challenges. As part of TD's acquisition of Layer 6, both organizations pledged to dedicate time and talent to put the power of AI to work for social good.

Layer 6 data scientists, are supporting a University of Toronto Computer Science Student working with University of Toronto Associate Professor Laura Rosella by developing advanced machine learning models to improve the health outcomes of people living with diabetes in Canada. The first research goal is to further sub-type patients identified with this highly prevalent chronic disease. The research will demonstrate opportunities for machine learning to enable more personalized and effective treatment, while providing more efficient use of health resources.

"Healthcare is one of the next frontiers for artificial intelligence to make a meaningful and positive impact on the lives of Canadians. It's also an opportunity for us to continue to lead the world in advancing Canadian AI talent and capabilities," says Tomi Poutanen, Co-Founder, Layer 6 and TD's Chief AI Officer. "The limitless potential for data to make personalized therapies, tailored approaches and early diagnosis accessible to all Canadians is what drives our team to push forward and continue to innovate."

TD's Investment in Healthcare

About TD Bank Group

The Toronto-Dominion Bank and its subsidiaries are collectively known as TD Bank Group ("TD" or the "Bank"). TD is the sixth largest bank in North America by branches and serves more than 25 million customers in three key businesses operating in a number of locations in financial centres around the globe: Canadian Retail, including TD Canada Trust, TD Auto Finance Canada, TD Wealth (Canada), TD Direct Investing, and TD Insurance; U.S. Retail, including TD Bank, America's Most Convenient Bank®, TD Auto Finance U.S., TD Wealth (U.S.), and an investment in TD Ameritrade; and Wholesale Banking, including TD Securities. TD also ranks among the world's leading online financial services firms, with approximately 12 million active online and mobile customers. TD had CDN$1.3 trillion in assets on July 31, 2018. The Toronto-Dominion Bank trades under the symbol "TD" on the Toronto and New York Stock Exchanges.

About the Creative Destruction Lab

The Creative Destruction Lab (CDL) is a seed-stage program for massively scalable, science-based companies. Its nine-month program pairs founders with experienced entrepreneurs and investors to set focused, measurable objectives with the goal of maximizing equity-value creation. Founded by Professor Ajay Agrawal in 2012 at the Rotman School of Management at the University of Toronto, the program has now expanded with locations in Vancouver, Calgary, Montreal, Halifax, and New York City.

Since its inception in 2012, companies that have participated in the CDL programs have created over $3 billion (CAD) in equity value. CDL Alumni include Thalmic Labs (Waterloo), Atomwise (San Francisco), Deep Genomics (Toronto), Nymi (Toronto), Automat (Montreal), Kyndi (Palo Alto), and Heuritech (Paris).

SOURCE TD Bank Group


These press releases may also interest you

at 11:45
SummaryProduct: Henna cones Issue: Chemical hazard / Product safety What to do: Stop using and selling them immediately and dispose of them in regular household garbage Who this is for: General public / Industry; Retail, Importers IssueHealth Canada...

at 11:30
The "Global Antibody Therapeutic Market: Focus on Format, Disease Area, Route of Administration, End Users, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033" report has been added to  ResearchAndMarkets.com's offering. The global...

at 11:30
XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid...

at 11:25
Manifest Technologies, Inc., developer of an AI-powered computational neuro-imaging platform for CNS disease, today unveiled the company after completing its initial funding and partnership with a top five global pharmaceutical company. Today, over...

at 11:08
Sunwave Health, a leader in healthcare technology, proudly announces the launch of MARA, a patent-pending, innovative AI Agent designed to transform the landscape of behavioral health documentation. Since its launch on October 25, 2023, MARA has...

at 11:04
MelliCell Inc. has been awarded a U.S. National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $275,000 to conduct research and development (R&D) work on "Industrial Scale Technology for Drug Development in Mature Human...



News published on and distributed by: